(4S,5R)-5-(2,4-difluorophenyl)-2-(hydroxymethyl)-4-methyl-6-(1H-1,2,4-triazol-1-yl)hexane-1,5-diol | 219872-89-6

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: (4S,5R)-5-(2,4-difluorophenyl)-2-(hydroxymethyl)-4-methyl-6-(1H-1,2,4-triazol-1-yl)hexane-1,5-diol
• 英文别名: (4S,5R)-5-(2,4-difluorophenyl)-2-(hydroxymethyl)-4-methyl-6-(1H-1,2,4-triazol-1-yl)-1,5-hexanediol；(4S,5R)-5-(2,4-difluorophenyl)-2-(hydroxymethyl)-4-methyl-6-(1,2,4-triazol-1-yl)hexane-1,5-diol
• CAS: 219872-89-6
• 化学式: C₁₆H₂₁F₂N₃O₃
• 分子量: 341.358
• InChiKey: LNZGUNVFYBBJNM-MEDUHNTESA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.8
• 重原子数：
  24
• 可旋转键数：
  8
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  91.4
• 氢给体数：
  3
• 氢受体数：
  7

反应信息

• 作为反应物：
  描述：

  7-[4-(Trifluoromethyl)phenyl]-2,4,6-heptatrienal 、 (4S,5R)-5-(2,4-difluorophenyl)-2-(hydroxymethyl)-4-methyl-6-(1H-1,2,4-triazol-1-yl)hexane-1,5-diol 在 对甲苯磺酸 作用下， 以 二氯甲烷 、 水 为溶剂， 反应 3.5h， 以61%的产率得到
  参考文献：
  名称：

  Carbon analogs of antifungal dioxane-triazole derivatives: Synthesis and in vitro activities

  摘要：

  A new series of triazole compounds possessing a carbon atom in place of a sulfur atom were efficiently synthesized and their in vitro antifungal activities were investigated. The carbon analogs showed excellent in vitro activity against Candida, Cryptococcus, and Aspergillus species. The MICs of compound 1c against C. albicans ATCC24433, C. neoformans TIMM1855, and A. fumigatus ATCC26430 were 0.016, 0.016, and 0.125 mu g/mL, respectively (MICs of fluconazole: 0.5, >4, and >4 mu g/mL; MICs of itraconazole: 0.125, 0.25, and 0.25 mu g/mL). (C) 2008 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2008.10.055
• 作为产物：
  描述：

  diethyl [(2S,3R)-3-(2,4-difluorophenyl)-3-hydroxy-2-methyl-4-(1H-1,2,4-triazol-1-yl)butyl]malonate 在 锂硼氢 作用下， 以 乙醇 为溶剂， 以81%的产率得到(4S,5R)-5-(2,4-difluorophenyl)-2-(hydroxymethyl)-4-methyl-6-(1H-1,2,4-triazol-1-yl)hexane-1,5-diol
  参考文献：
  名称：

  Carbon analogs of antifungal dioxane-triazole derivatives: Synthesis and in vitro activities

  摘要：

  A new series of triazole compounds possessing a carbon atom in place of a sulfur atom were efficiently synthesized and their in vitro antifungal activities were investigated. The carbon analogs showed excellent in vitro activity against Candida, Cryptococcus, and Aspergillus species. The MICs of compound 1c against C. albicans ATCC24433, C. neoformans TIMM1855, and A. fumigatus ATCC26430 were 0.016, 0.016, and 0.125 mu g/mL, respectively (MICs of fluconazole: 0.5, >4, and >4 mu g/mL; MICs of itraconazole: 0.125, 0.25, and 0.25 mu g/mL). (C) 2008 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2008.10.055

文献信息

• Amide-type triazole compounds
  申请人：SANKYO COMPANY, LIMITED

  公开号：US20030176480A1

  公开（公告）日：2003-09-18

  A compound of formula (I) or a pharmacologically acceptable prodrug or salt thereof which exhibits excellent antifungal activity: 1 wherein Ar 1 represents a phenyl group or the like; Ar 2 represents a phenylene group or the like. X represents a sulfur atom or a methylene group. R 1 represents a hydrogen atom or a C 1-3 alkyl group; R 2 represents a hydrogen atom or a C 1-3 alkyl group; and R 3 represents an optionally substituted C 6-10 aryl group or the like. Fungal infections may be prevented and/or treated by administering said compound (I) or said prodrug or salt thereof.

  一种具有出色抗真菌活性的化合物，其化学式为（I）或其药理学上可接受的前药或盐：其中Ar1代表苯基或类似物；Ar2代表苯基或类似物。X代表硫原子或亚甲基基团。R1代表氢原子或C1-3烷基基团；R2代表氢原子或C1-3烷基基团；R3代表可选择取代的C6-10芳基基团或类似物。通过给予该化合物（I）或其前药或盐可预防和/或治疗真菌感染。
• TRIAZOLE COMPOUNDS HAVING AMIDE LINKAGE
  申请人：Sankyo Company, Limited

  公开号：EP1284267A1

  公开（公告）日：2003-02-19

  The present invention provides a compound of formula (I) or a pharmacologically acceptable prodrug or salt thereof which exhibits excellent antifungal activity: [wherein Ar1 represents a phenyl group or the like; Ar2 represents a phenylene group or the like; X represents a sulfur atom or a methylene group; R1 represents a hydrogen atom or a C1-3 alkyl group; R2 represents a hydrogen atom or a C1-3 alkyl group; and R3 represents an optionally substituted C6-10 aryl group or the like].

  本发明提供了一种具有优异抗真菌活性的式(I)化合物或其药理学上可接受的原药或盐： [其中 Ar1 代表苯基或类似物；Ar2 代表亚苯基或类似物；X 代表硫原子或亚甲基；R1 代表氢原子或 C1-3 烷基；R2 代表氢原子或 C1-3 烷基；R3 代表任选取代的 C6-10 芳基或类似物]。
• Triazole derivatives having antifungal activity
  申请人：Sankyo Company Limited

  公开号：EP1083175B1

  公开（公告）日：2003-07-02
• US6337403B1
  申请人：——

  公开号：US6337403B1

  公开（公告）日：2002-01-08
• US6391903B1
  申请人：——

  公开号：US6391903B1

  公开（公告）日：2002-05-21